| One year update on the COVID-19 pandemic: Where are we now? SK Mishra, T Tripathi Acta tropica 214, 105778, 2021 | 239 | 2021 |
| Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2 P Kalita, AK Padhi, KYJ Zhang, T Tripathi Microbial Pathogenesis 145, 104236, 2020 | 216 | 2020 |
| Current and novel therapeutic molecules and targets in Alzheimer's disease A Kumar, CM Nisha, C Silakari, I Sharma, K Anusha, N Gupta, P Nair, ... Journal of the Formosan Medical Association 115 (1), 3-10, 2016 | 173 | 2016 |
| Molecular Docking and In Silico ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of β‐Secretase CM Nisha, A Kumar, P Nair, N Gupta, C Silakari, T Tripathi, A Kumar Advances in bioinformatics 2016 (1), 9258578, 2016 | 145 | 2016 |
| Aminoacyl-tRNA synthetases: Structure, function, and drug discovery V Rajendran, P Kalita, H Shukla, A Kumar, T Tripathi International journal of biological macromolecules 111, 400-414, 2018 | 125 | 2018 |
| Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy S Verma, A Kumar, T Tripathi, A Kumar Journal of Pharmacy and Pharmacology 70 (8), 985-993, 2018 | 117 | 2018 |
| An efficient protocol to enhance recombinant protein expression using ethanol in Escherichia coli G Chhetri, P Kalita, T Tripathi MethodsX 2, 385-391, 2015 | 115 | 2015 |
| Molecular dynamics simulation of protein and protein–ligand complexes R Shukla, T Tripathi Computer-aided drug design, 133-161, 2020 | 88 | 2020 |
| High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance AK Padhi, R Shukla, P Saudagar, T Tripathi Iscience 24 (1), 2021 | 76* | 2021 |
| Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations AK Padhi, A Seal, JM Khan, M Ahamed, T Tripathi European journal of pharmacology 894, 173836, 2021 | 74* | 2021 |
| Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase R Shukla, H Shukla, A Sonkar, T Pandey, T Tripathi Journal of Biomolecular Structure and Dynamics 36 (8), 2045-2057, 2018 | 72 | 2018 |
| Frontiers in protein structure, function, and dynamics DB Singh, T Tripathi Springer 10, 978-981, 2020 | 71 | 2020 |
| Development of multi-epitope driven subunit vaccine against Fasciola gigantica using immunoinformatics approach P Kalita, DL Lyngdoh, AK Padhi, H Shukla, T Tripathi International journal of biological macromolecules 138, 224-233, 2019 | 69 | 2019 |
| Can SARS-CoV-2 accumulate mutations in the S-protein to increase pathogenicity? AK Padhi, T Tripathi ACS Pharmacology & Translational Science 3 (5), 1023-1026, 2020 | 63 | 2020 |
| Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility H Shukla, R Shukla, A Sonkar, T Pandey, T Tripathi Scientific reports 7 (1), 1058, 2017 | 63 | 2017 |
| Accelerating COVID-19 research using molecular dynamics simulation AK Padhi, SL Rath, T Tripathi The Journal of Physical Chemistry B 125 (32), 9078-9091, 2021 | 60 | 2021 |
| Autophagy modulation as a treatment of amyloid diseases Z Mputhia, E Hone, T Tripathi, T Sargeant, R Martins, P Bharadwaj Molecules 24 (18), 3372, 2019 | 58 | 2019 |
| Calculation of thermodynamic parameters of protein unfolding using far-ultraviolet circular dichroism T Tripathi J Proteins Proteomics 4 (2), 85-91, 2013 | 56 | 2013 |
| Identification of potential inhibitors of Fasciola gigantica thioredoxin1: computational screening, molecular dynamics simulation, and binding free energy studies R Shukla, H Shukla, P Kalita, A Sonkar, T Pandey, DB Singh, A Kumar, ... Journal of Biomolecular Structure and Dynamics 36 (8), 2147-2162, 2018 | 52 | 2018 |
| Advances in protein molecular and structural biology methods T Tripathi, VK Dubey Academic Press, 2022 | 49 | 2022 |
Rohit ShuklaUniversity of South Florida在 usf.edu 的电子邮件经过验证
